| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $672 | -98.5% |
| R&D Expense | $1.4M | +162.4% |
| SG&A Expense | $893K | -10.0% |
| Operating Income | -$8.8M | +28.2% |
| Net Income | -$8.4M | +30.8% |
| EPS (Basic) | -$4.14 | -590.0% |
| EPS (Diluted) | -$4.14 | -590.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $953K | -45.0% |
| Short-term Investments | $5.2M | -52.4% |
| Accounts Receivable | $183 | -52.3% |
| Current Assets | $6.4M | -50.5% |
| Total Assets | $6.5M | -50.4% |
| Current Liabilities | $407K | -14.1% |
| Total Liabilities | $407K | -27.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.5M | +10.0% |
| Capital Expenditures | $49K | +11.3% |
| Investing Cash Flow | $6.2M | +155.0% |
| Financing Cash Flow | -$398K | — |
| Free Cash Flow | -$6.6M | +9.9% |
| Stockholders' Equity |
| $6.1M |
| -51.4% |